查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1833614

2032 年溫控包裝市場預測：按產品類型、系統類型、可用​​性、溫度範圍、最終用戶和地區進行的全球分析

Temperature-Controlled Packaging Market Forecasts to 2032 - Global Analysis By Product Type, System Type, Usability, Temperature Range, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球溫控包裝市場預計在 2025 年達到 323 億美元，到 2032 年將達到 886 億美元，預測期內的複合年成長率為 15.5%。

溫控包裝可確保在運輸和儲存過程中需要嚴格溫度調節的產品的安全處理。該市場廣泛應用於藥品、生技藥品、疫苗、生鮮食品、水產品和冷凍食品，在全球供應鏈中發揮關鍵作用。由於生技藥品的成長、生鮮產品的電商配送以及更嚴格的安全法規，對溫控包裝的需求正在成長。創新技術包括智慧包裝、可重複使用的解決方案和環保隔熱材料。隨著供應鏈彈性和永續性受到關注，溫控包裝已成為確保產品品質的關鍵。

DHL表示，2022年將投資4億美元擴大其醫藥級溫控物流，新增300萬平方英尺的合規設施。

生物製藥的成長

生物製藥產業的擴張是溫控包裝市場的主要驅動力。生技藥品、疫苗以及細胞和基因療法本質上都具有揮發性，需要嚴格、穩定的溫度控制，以確保從生產到患者整個生命週期的有效性和安全性。任何偏差都可能導致這些高價值產品失效，因此堅固的包裝是供應鏈中不可或缺的一部分。這種依賴催生了對能夠確保產品完整性的先進包裝解決方案的直接且不斷成長的需求，從而隨著越來越多的生技藥品獲得監管機構核准並進入市場，推動整個市場向前發展。

包裝成本高

相變材料、物聯網感測器和隔熱材料等先進組件的整合增加了托運商和貨櫃的初始投資。這些高成本對於小型製藥公司和物流供應商來說尤其沉重，擠壓了利潤率，並限制了他們可靠地運輸產品的能力。這些經濟障礙正在減緩採用率，尤其是在對價格敏感的新興市場，並持續限制產業的整體成長潛力。

永續包裝解決方案

市場對可回收、可重複使用、可生物分解且不影響熱性能的包裝材料的需求日益成長。開發環保設計的公司，例如採用植物來源凝膠和可堆肥隔熱材料的系統，能夠脫穎而出，吸引注重永續性的新客戶。這種轉變不僅是監管方面的回應，更是與企業永續性目標相符的策略性舉措，能夠在生命科學物流領域開闢重要的新收益來源和品牌知名度。

產品召回

包裝系統一旦發生故障，就可能導致溫度升高，危及整批高價值藥品的運輸，並迫使企業進行代價高昂的召回。此類事件不僅會因產品處置和包裝更換而造成直接經濟損失，還會對藥廠和包裝商造成持久的聲譽損害。這會削弱客戶信心，並引發監管部門的更嚴格審查。因此，可靠性和久經考驗的性能對於在競爭激烈的市場環境中保持領先至關重要。

COVID-19的影響：

新冠疫情為溫控包裝市場帶來了前所未有的推手。全球分發溫敏型疫苗（尤其是需要超低溫鏈條件的mRNA疫苗）的迫切性，導致對先進包裝解決方案的需求激增。這場危機凸顯了高韌性低溫運輸的戰略重要性，從而加速了投資，促進了包裝設計的快速創新，並提高了對物流能力的認知。這場疫情從根本上改變了產業的觀點，永久提升了可靠的溫控包裝在全球衛生安全和供應鏈策略中的作用。

預測期內，絕緣托運人市場預計將成為最大的市場

由於直接運送患者和臨床試驗樣本在不斷擴展的小包裹式物流模式中發揮重要作用，預計隔熱運輸箱細分市場將在預測期內佔據最大市場佔有率。這些運輸箱為運輸小型高價值貨物（例如特殊藥品和臨床樣本）提供了一種經濟高效且靈活的解決方案。其輕量化設計和一次性使用的特性簡化了最終用戶的物流流程。此外，輕質高性能隔熱材料的不斷創新確保了其持續的市場競爭力，使其成為滿足行業大部分運輸需求的首選解決方案。

預計主動系統部門在預測期內將實現最高複合年成長率

預計主動系統細分市場將在預測期內實現最高成長率，這得益於運輸複雜生技藥品和細胞治療產品的需求日益成長，這些產品需要嚴格且長時間的溫度控制。與被動解決方案不同，主動系統使用外部供電組件來維持精確的溫度，這對於最精密產品的國際運輸和多日運輸至關重要。此外，即時GPS和溫度監控的整合為法規遵從性和品質保證提供了寶貴的數據線索，這不僅證明了高風險、高價值藥物的高成本是合理的，也推動了市場的快速普及。

佔比最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其強大的生物製藥製造基礎、全球領先的物流公司以及嚴格的低溫運輸標準法規結構。該地區是生技藥品和臨床試驗的創新中心，對先進包裝有內在的需求。此外，完善的醫療基礎設施和高昂的醫療支出正在推動新型先進包裝技術的快速應用。美國是大型製藥和包裝公司高度集中的地區，形成了協同效應的生態系統。

複合年成長率最高的地區：

預計亞太地區在預測期內將呈現最高的複合年成長率，這得益於藥品產量的擴大、醫療保健可及性的改善以及基礎設施的大力發展。印度和中國等國家正在崛起成為全球製藥強國，而收入的成長也刺激了國內對先進的溫控藥品的需求。為了支持這一成長，各國政府也大力投資現代化低溫運輸物流。這種充滿活力的環境，加上對品質和合規性的日益重視，為該全部區域加速採用溫控包裝解決方案提供了肥沃的土壤。

免費客製化服務：

此報告的訂閱者可以使用以下免費自訂選項之一：

  • 公司簡介
    • 對最多三家其他市場公司進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球溫控包裝市場（依產品類型）

  • 絕緣運輸公司
  • 保溫容器
  • 冷媒
    • 凝膠包
    • PCM（相變材料）
    • 乾冰
    • 液態氮
  • 溫度監測組件

6. 全球溫控包裝市場（依系統類型）

  • 主動系統
  • 被動系統

7. 全球溫控包裝市場（依用途）

  • 免洗系統
  • 可重複使用/可回收系統

8. 全球溫控包裝市場（依溫度範圍）

  • 冷凍（-15 度C至 -25 度C或更低）
  • 冷藏（2度C至8度C）
  • 環境溫度（15°C至25°C）
  • 低溫（低於-150 度C）

9. 全球溫控包裝市場（依最終用戶）

  • 醫療保健和製藥
    • 臨床試驗
    • 生技藥品及特殊藥物
    • 疫苗
    • 非處方藥
  • 食品/飲料
    • 新鮮農產品
    • 肉類、家禽、魚貝類
    • 乳製品
    • RTE
  • 化學品
  • 其他最終用戶

第 10 章全球溫控包裝市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Pelican BioThermal（Peli BioThermal）
  • Sonoco ThermoSafe
  • Cold Chain Technologies
  • Cryopak
  • va-Q-tec
  • CSafe Global
  • Envirotainer
  • Sofrigam
  • Intelsius（DGP Intelsius）
  • Nordic Cold Chain Solutions
  • Tower Cold Chain Solutions
  • TemperPack
  • Sealed Air
  • Chill-Pak（Engineered Packaging/Chill-Pak）
  • CoolPac
  • Pluss Advanced Technologies
Product Code: SMRC31447

According to Stratistics MRC, the Global Temperature-Controlled Packaging Market is accounted for $32.3 billion in 2025 and is expected to reach $88.6 billion by 2032 growing at a CAGR of 15.5% during the forecast period. The Temperature-Controlled Packaging ensures safe handling of products that require strict thermal regulation during transportation and storage. Widely used in pharmaceuticals, biologics, vaccines, fresh produce, seafood, and frozen goods, this market plays a critical role in global supply chains. Demand is increasing with growth in biologics, e-commerce delivery of perishables, and stricter safety regulations. Innovations include smart packaging, reusable solutions, and eco-friendly insulation materials. As supply chain resilience and sustainability gain focus, temperature-controlled packaging is becoming indispensable for product quality assurance.

According to DHL, $400 million was invested in 2022 to expand pharma-grade temperature-controlled logistics, adding 3 million sq ft of compliant facilities.

Market Dynamics:

Driver:

Growth in Biopharmaceuticals

The expansion of the biopharmaceutical sector is a primary engine for the temperature-controlled packaging market. Biologics, vaccines, and cell and gene therapies are inherently unstable and demand strict, unbroken thermal regimes to maintain their efficacy and safety from production to patient. Any deviation can render these high-value products useless, making robust packaging a non-negotiable part of the supply chain. This dependency creates a direct and growing demand for advanced packaging solutions that can ensure product integrity, thereby propelling the entire market forward significantly as more biologics receive regulatory approval and enter the market.

Restraint:

High Packaging Costs

The integration of sophisticated components like phase change materials, IoT sensors, and insulated materials drives up the initial investment for shippers and containers. These high costs can be particularly prohibitive for smaller pharmaceutical companies and logistics providers, potentially squeezing their profit margins or limiting their ability to ship products reliably. This financial hurdle can slow down adoption rates, especially in price-sensitive emerging markets, acting as a persistent restraint on the overall growth potential of the industry.

Opportunity:

Sustainable Packaging Solutions

There is a growing market appetite for recyclable, reusable, and biodegradable packaging materials that do not compromise thermal performance. Companies that pioneer eco-friendly designs, such as systems using plant-based gels or compostable insulation, can differentiate themselves and capture a new, sustainability-conscious customer segment. This shift is not merely a regulatory response but a strategic move to align with corporate sustainability goals, opening up a significant new revenue stream and enhancing brand reputation within the life sciences logistics sector.

Threat:

Product Recalls

A single failure in the packaging system, leading to temperature excursions, can compromise an entire shipment of high-value pharmaceuticals, forcing a costly recall. Beyond immediate financial losses from destroying the product and replacing the packaging, such events inflict lasting reputational damage on both the pharmaceutical manufacturer and the packaging provider. This erodes customer trust and can trigger stringent regulatory scrutiny, making reliability and proven performance critical factors for maintaining a strong position in this high-stakes market environment.

Covid-19 Impact:

The COVID-19 pandemic served as an unprecedented catalyst for the temperature-controlled packaging market. The global urgency to distribute temperature-sensitive vaccines, particularly mRNA-based ones requiring ultra-cold chain conditions, triggered a massive surge in demand for advanced packaging solutions. This crisis underscored the strategic importance of a resilient cold chain, leading to accelerated investments, rapid innovation in packaging designs, and a heightened awareness of logistics capabilities. The pandemic fundamentally shifted industry perspectives, permanently elevating the role of reliable temperature-controlled packaging in global health security and supply chain strategy.

The insulated shippers segment is expected to be the largest during the forecast period

The insulated shippers segment is expected to account for the largest market share during the forecast period fueled by its critical role in the expanding parcel-based logistics model for direct-to-patient and clinical trial distributions. These shippers offer a cost-effective and highly flexible solution for transporting smaller, high-value consignments like specialty drugs and clinical samples. Their lightweight design and single-use nature simplify the logistics process for end-users. Furthermore, continuous innovation in lightweight, high-performance insulation materials ensures their continued relevance, making them the workhorse solution for a vast portion of the industry's shipping needs.

The active systems segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the active systems segment is predicted to witness the highest growth rate driven by the escalating need to transport complex biologics and cell therapies that require stringent, long-duration temperature control. Unlike passive solutions, active systems use externally powered components to maintain precise temperatures, making them indispensable for international and multi-day shipments of the most sensitive products. Moreover, the integration of real-time GPS and temperature monitoring provides an invaluable data trail for regulatory compliance and quality assurance, justifying their higher cost for high-risk, high-value pharmaceuticals and fueling their rapid market adoption.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share driven by robust biopharmaceutical manufacturing base, the presence of major global logistics players, and a stringent regulatory framework that mandates rigorous cold chain standards. The region is a hub for innovation in biologics and clinical trials, creating inherent demand for advanced packaging. Additionally, well-established healthcare infrastructure and high healthcare spending empower the rapid adoption of new, sophisticated packaging technologies. The concentration of leading pharmaceutical and packaging companies in the U.S. creates a synergistic ecosystem that consolidates the region's dominant position in the global market landscape.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR fueled by a powerful combination of expanding pharmaceutical production, improving healthcare access, and significant infrastructure development. Countries like India and China are emerging as global pharmaceutical powerhouses, while rising incomes are increasing domestic demand for advanced, temperature-sensitive medicines. Governments are also investing heavily in modernizing their cold chain logistics to support this growth. This dynamic environment, coupled with a growing focus on quality and compliance, creates a fertile ground for the accelerated adoption of temperature-controlled packaging solutions across the region.

Key players in the market

Some of the key players in Temperature-Controlled Packaging Market include Pelican BioThermal, Sonoco ThermoSafe, Cold Chain Technologies, Cryopak, va-Q-tec, CSafe Global, Envirotainer, Sofrigam, Intelsius (DGP Intelsius), Nordic Cold Chain Solutions, Tower Cold Chain Solutions, TemperPack, Sealed Air, Chill-Pak (Engineered Packaging / Chill-Pak), CoolPac, and Pluss Advanced Technologies.

Key Developments:

In September 2025, Pelican biothermal showcased next chapter of cold chain innovation at LogiPharma US focusing on advanced temperature-controlled packaging solutions for life sciences. They provide cost-effective thermal packaging delivering measurable ROI and expanding their portfolio through acquisition.

In March 2025, Cold Chain Technologies acquired Global Cold Chain Solutions, a leading provider of passive cold chain solutions in Australia and India, to expand its Asia-Pacific presence and capabilities.

In February 2025, CSafe Global launched the AcuTemp Plus Series passive packaging designed for cold chain pharma, clinical trials, and cell and gene therapies featuring high-performing vacuum insulated panels and phase change materials for enhanced temperature control.

Product Types Covered:

  • Insulated Shippers
  • Insulated Containers
  • Refrigerants
  • Temperature Monitoring Components

System Types Covered:

  • Active Systems
  • Passive Systems

Usabilities Covered:

  • Single-Use/Disposable Systems
  • Reusable/Returnable Systems

Temperature Ranges Covered:

  • Frozen (<= -15°C to -25°C)
  • Chilled (2°C to 8°C)
  • Ambient (15°C to 25°C)
  • Cryogenic (<= -150°C)

End Users Covered:

  • Healthcare & Pharmaceuticals
  • Food & Beverages
  • Chemicals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Temperature-Controlled Packaging Market, By Product Type

  • 5.1 Introduction
  • 5.2 Insulated Shippers
  • 5.3 Insulated Containers
  • 5.4 Refrigerants
    • 5.4.1 Gel Packs
    • 5.4.2 PCMs (Phase Change Materials)
    • 5.4.3 Dry Ice
    • 5.4.4 Liquid Nitrogen
  • 5.5 Temperature Monitoring Components

6 Global Temperature-Controlled Packaging Market, By System Type

  • 6.1 Introduction
  • 6.2 Active Systems
  • 6.3 Passive Systems

7 Global Temperature-Controlled Packaging Market, By Usability

  • 7.1 Introduction
  • 7.2 Single-Use/Disposable Systems
  • 7.3 Reusable/Returnable Systems

8 Global Temperature-Controlled Packaging Market, By Temperature Range

  • 8.1 Introduction
  • 8.2 Frozen (<= -15°C to -25°C)
  • 8.3 Chilled (2°C to 8°C)
  • 8.4 Ambient (15°C to 25°C)
  • 8.5 Cryogenic (<= -150°C)

9 Global Temperature-Controlled Packaging Market, By End User

  • 9.1 Introduction
  • 9.2 Healthcare & Pharmaceuticals
    • 9.2.1 Clinical Trials
    • 9.2.2 Biologics and Specialty Drugs
    • 9.2.3 Vaccines
    • 9.2.4 Over-the-Counter (OTC) Medicines
  • 9.3 Food & Beverages
    • 9.3.1 Fresh Produce
    • 9.3.2 Meat, Poultry, and Seafood
    • 9.3.3 Dairy Products
    • 9.3.4 Ready-to-Eat Meals
  • 9.4 Chemicals
  • 9.5 Other End Users

10 Global Temperature-Controlled Packaging Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Pelican BioThermal (Peli BioThermal)
  • 12.2 Sonoco ThermoSafe
  • 12.3 Cold Chain Technologies
  • 12.4 Cryopak
  • 12.5 va-Q-tec
  • 12.6 CSafe Global
  • 12.7 Envirotainer
  • 12.8 Sofrigam
  • 12.9 Intelsius (DGP Intelsius)
  • 12.10 Nordic Cold Chain Solutions
  • 12.11 Tower Cold Chain Solutions
  • 12.12 TemperPack
  • 12.13 Sealed Air
  • 12.14 Chill-Pak (Engineered Packaging / Chill-Pak)
  • 12.15 CoolPac
  • 12.16 Pluss Advanced Technologies

List of Tables

  • Table 1 Global Temperature-Controlled Packaging Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Temperature-Controlled Packaging Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Temperature-Controlled Packaging Market Outlook, By Insulated Shippers (2024-2032) ($MN)
  • Table 4 Global Temperature-Controlled Packaging Market Outlook, By Insulated Containers (2024-2032) ($MN)
  • Table 5 Global Temperature-Controlled Packaging Market Outlook, By Refrigerants (2024-2032) ($MN)
  • Table 6 Global Temperature-Controlled Packaging Market Outlook, By Gel Packs (2024-2032) ($MN)
  • Table 7 Global Temperature-Controlled Packaging Market Outlook, By PCMs (Phase Change Materials) (2024-2032) ($MN)
  • Table 8 Global Temperature-Controlled Packaging Market Outlook, By Dry Ice (2024-2032) ($MN)
  • Table 9 Global Temperature-Controlled Packaging Market Outlook, By Liquid Nitrogen (2024-2032) ($MN)
  • Table 10 Global Temperature-Controlled Packaging Market Outlook, By Temperature Monitoring Components (2024-2032) ($MN)
  • Table 11 Global Temperature-Controlled Packaging Market Outlook, By System Type (2024-2032) ($MN)
  • Table 12 Global Temperature-Controlled Packaging Market Outlook, By Active Systems (2024-2032) ($MN)
  • Table 13 Global Temperature-Controlled Packaging Market Outlook, By Passive Systems (2024-2032) ($MN)
  • Table 14 Global Temperature-Controlled Packaging Market Outlook, By Usability (2024-2032) ($MN)
  • Table 15 Global Temperature-Controlled Packaging Market Outlook, By Single-Use/Disposable Systems (2024-2032) ($MN)
  • Table 16 Global Temperature-Controlled Packaging Market Outlook, By Reusable/Returnable Systems (2024-2032) ($MN)
  • Table 17 Global Temperature-Controlled Packaging Market Outlook, By Temperature Range (2024-2032) ($MN)
  • Table 18 Global Temperature-Controlled Packaging Market Outlook, By Frozen (<= -15°C to -25°C) (2024-2032) ($MN)
  • Table 19 Global Temperature-Controlled Packaging Market Outlook, By Chilled (2°C to 8°C) (2024-2032) ($MN)
  • Table 20 Global Temperature-Controlled Packaging Market Outlook, By Ambient (15°C to 25°C) (2024-2032) ($MN)
  • Table 21 Global Temperature-Controlled Packaging Market Outlook, By Cryogenic (<=-150°C) (2024-2032) ($MN)
  • Table 22 Global Temperature-Controlled Packaging Market Outlook, By End User (2024-2032) ($MN)
  • Table 23 Global Temperature-Controlled Packaging Market Outlook, By Healthcare & Pharmaceuticals (2024-2032) ($MN)
  • Table 24 Global Temperature-Controlled Packaging Market Outlook, By Clinical Trials (2024-2032) ($MN)
  • Table 25 Global Temperature-Controlled Packaging Market Outlook, By Biologics and Specialty Drugs (2024-2032) ($MN)
  • Table 26 Global Temperature-Controlled Packaging Market Outlook, By Vaccines (2024-2032) ($MN)
  • Table 27 Global Temperature-Controlled Packaging Market Outlook, By Over-the-Counter (OTC) Medicines (2024-2032) ($MN)
  • Table 28 Global Temperature-Controlled Packaging Market Outlook, By Food & Beverages (2024-2032) ($MN)
  • Table 29 Global Temperature-Controlled Packaging Market Outlook, By Fresh Produce (2024-2032) ($MN)
  • Table 30 Global Temperature-Controlled Packaging Market Outlook, By Meat, Poultry, and Seafood (2024-2032) ($MN)
  • Table 31 Global Temperature-Controlled Packaging Market Outlook, By Dairy Products (2024-2032) ($MN)
  • Table 32 Global Temperature-Controlled Packaging Market Outlook, By Ready-to-Eat Meals (2024-2032) ($MN)
  • Table 33 Global Temperature-Controlled Packaging Market Outlook, By Chemicals (2024-2032) ($MN)
  • Table 34 Global Temperature-Controlled Packaging Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.